WAM
IMMU

Wolverine Asset Management’s Immunomedics Inc IMMU Stock Holding History

Wolverine Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-59,991
Closed -$5.1M – 2101
2020
Q3 		$5.1M Buy
59,991
+59,935
+107,027% +$3.03M 0.05% 217
2020
Q2 		$1K Buy
+56
New +$1.64K ﹤0.01% 1511
2017
Q4 		– Sell
-410,446
Closed -$4.84M – 1668
2017
Q3 		$5.74M Buy
+410,446
New +$4.09M 0.06% 235
2015
Q1 		– Sell
-29,300
Closed -$127K – 2309
2014
Q4 		$140K Buy
29,300
+3,300
+13% +$13K ﹤0.01% 1088
2014
Q3 		$96K Buy
26,000
+10,800
+71% +$36.5K ﹤0.01% 1322
2014
Q2 		$55K Buy
15,200
+8,900
+141% +$32.7K ﹤0.01% 1352
2014
Q1 		$26K Sell
6,300
-2,100
-25% -$10.4K ﹤0.01% 1555
2013
Q4 		$38K Buy
8,400
+7,700
+1,100% +$34.3K ﹤0.01% 1865
2013
Q3 		$4K Hold
700
– – ﹤0.01% 2445
2013
Q2 		$3K Buy
+700
New +$2.3K ﹤0.01% 2462

Wolverine Asset Management's IMMU Position: Q4 2020 in Review

Wolverine Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 59,991 shares — an estimated $5.1M sold.

Wolverine Asset Management first reported a position in IMMU in Q2 2013 and held it in 10 quarters. The position peaked at $5.74M in Q3 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Wolverine Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 59,991 Immunomedics Inc shares in Q4 2020, an estimated $5.1M.
  • Wolverine Asset Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 10 quarters.
  • Wolverine Asset Management's Immunomedics Inc position peaked at $5.74M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Wolverine Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.